组蛋白精氨酸甲基转移酶5在胃癌组织中的表达及其意义

doi:10.13481/j.1671-587x.20160423

摘要/Abstract

摘要：

目的：探讨组蛋白精氨酸甲基转移酶5（PRMT5）在胃癌组织中的表达，阐明PRMT5与胃癌发生及临床病理学特征之间的关系，为胃癌的防治提供新的靶点。方法：43例人胃癌组织及15例癌旁正常胃组织样本分别作为胃癌组和对照组，采用免疫组织化学方法检测2组样本中PRMT5的高表达率。结果：与对照组（13.3%）比较，胃癌组胃癌组织中PRMT5高表达率（72.1%）明显升高（P < 0.05）。对照组弱阳性表达标本中，棕黄色颗粒主要位于细胞浆中，表现为弱到中等强度表达，细胞核染色较少；高分化胃癌标本中，棕黄色颗粒主要位于细胞浆中，表现为中等和强表达，细胞核染色较多；中、低分化和未分化胃癌标本中棕黄色颗粒主要位于细胞浆和细胞核中，细胞核表现为强表达。PRMT5高表达率与肿瘤大小、分化程度、浸润深度、淋巴结转移情况及TNM分期有关联（P < 0.05或P < 0.01），与患者的性别和年龄无关联（P < 0.05）。结论：PRMT5高表达可能对胃癌的发生发展起促进作用。

关键词: 胃肿瘤, 组蛋白精氨酸甲基转移酶5, 免疫组织化学

Abstract:

Objective: To investigate the expression of protein arginine methyltransferase 5 (PRMT5) in the gastric cancer tissue,and to explore the relationship between the PRMT5 expression and the occurrence and the clinicopathologic characteristics of gastric cancer, and to find a new treatment target for gastric cancer. Methods: Forty-three cases of gastric cancer tissue and 15 cases of adjacent normal gastric tissue were used as gastric cancer group and control group, respectively. The immunohistochemical staining was used to detect the expression of PRMT5 in the specimens. Results: Compared with control group (13.3%), the expression rate of PRMT5 in gastric cancer group(72.1%) was significantly increased (P < 0.05). In control group, there was some weak positive expression of PRMT5, the expressions were weak or moderate, the tan particles mainly located in the cytoplasm, less in the nuclei.In high differentiation gastric cancer specimens, the tan particles mainly located in the cytoplasm and more in nuclei, characterized by medium or strong expressions.In poorly differentiated and undifferentiated gastric cancer specimens, the tan particles mainly located in the cytoplasm and nucleus, and strongly expressed in nucleus. The higher expression of PRMT5 was associated with the size of tumor diameter, degree of differentition,depth of invasion, degree of lymph node metastasis, and TNM stage(P < 0.05 or P < 0.01), but had no correlation with the gender and age of patients(P > 0.05). Conclusion: High expression of PRMT5 may play an important role in the occurrence and development of gastric cancer.

Key words: stomach neoplasms, protein arginine methyltransferase 5, immunohistochemistry

中图分类号:

R735.2

孔桂美, 王继军, 陶文华, 卜平, 钱锋. 组蛋白精氨酸甲基转移酶5在胃癌组织中的表达及其意义[J]. 吉林大学学报(医学版), 2016, 42(04): 753-756.

KONG Guimei, WANG Jijun, TAO Wenhua, BU Ping, QIAN Feng. Expression of PRMT5 in human gastric cancer tissue and its significance[J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 753-756.

参考文献

[1] 李莉娜, 史锐敏, 王翠莲. 胃癌组织中TRAP1的表达及意义[J]. 临床与实验病理学杂志,2015, 31(3): 323-325.

[2] 王成艳, 金杯, 潘景轩. 稳定表达PRMT5蛋白的食管癌细胞株的建立及其对细胞增殖的影响[J]. 解剖学研究, 2013, 35(3):195-199.

[3] Jenuwein T, Allis CD. Translating the histone code [J]. Science,2001, 293(5532):1074-1080.

[4] Ren J , Wang Y, Liang Y, et al. Methylation of ribosomal protein S10 by protein arginine methyltransferase 5 regulates ribosome biogenesis [J]. J Biol Chem,2010, 285(17):12695-12705.

[5] Zhou Z, Sun X, Zou Z, et al. PRMT5 regulates Golgi apparatus structure through methylation of the golgin GM130[J]. Cell Res, 2010, 20(9):1023-1033.

[6] Mallappa C, Hu YJ, Shamulailatpam P, et al. The expression of myogenic microRNAs indirectly requires protein arginine methyltransferase (Prmt)5 but directly requires Prmt4[J]. Nucl Acids Res, 2011, 39(4):1243-1255.

[7] Chung J, Karkhanis V, Tae S, et al. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing [J]. J Biol Chem, 2013, 288(49): 35534-35547.

[8] Gu Z, Gao S, Zhang F, et al. Protein arginine methyltransferase 5 is essential for growth of lung cancer cells [J]. Biochem J, 2012, 446(2): 235-241.

[9] Gu Z, Li Y, Lee P, et al. Protein arginine methyltransferase 5 functions in opposite ways in the cytoplasm and nucleus of prostate cancer cells [J]. PLoS One, 2012, 7(8):e44033.

[10] Yang F, Wang J, Ren HY, et al. Proliferative role of TRAF4 in breast cancer by upregulating PRMT5 nuclear expression [J]. Tumour Biol, 2015, 36(8): 5901-5911.

[11] Powers MA , Fay MM, Factor RE, et al. Protein arginine methyltransferase 5 accelerates tumor growth by arginine methylation of the tumor suppressor programmed cell death 4[J]. Cancer Res, 2011, 71(16):5579-5587.

[12] Liang JJ, Wang Z, Chiriboga L, et al. The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors [J]. J Urol, 2007, 177(5):1918-1922.

[13] Paik WK, Kim S. Enzymatic methylation of protein fractions from calf thymus nuclei [J]. Biochem Biophys Res Commun, 1967, 29(1):14-20.

[14] Zhang T, Günther S, Looso M, et al. Prmt5 is a regulator of muscle stem cell expansion in adult mice[J]. Nat Commun, 2015, 6: 7140.

[15] Wang Y, Li Q, Liu C, et al. Protein arginine methyltransferase 5 (Prmt5) is required for germ cell survival during mouse embryonic development[J]. Biol Reprod, 2015, 92(4): 104.

[16] Likhite N, Jackson CA, Liang MS, et al. The protein arginine methyltransferase PRMT5 promotes D2-like dopamine receptor signaling[J]. Sci Signal, 2015, 8(402): ra115.

[17] Pal S, Vishwanath SN, Erdjument-Bromage H, et al. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes[J]. Mol Cell Biol, 2004, 24 (21):9630-9645.

[18] Deng Z, Matsuda K, Tanikawa C, et al. Late Cornified Envelope Group Ⅰ, a novel target of p53, regulates PRMT5 activity[J]. Neoplasia, 2014, 16(8): 656-664.

[19] Cho EC, Zheng S, Munro S, et al. Arginine methylation controls growth regulation by E2F-1[J]. EMBO J, 2012, 31 (7): 1785-1797.

[20] Tanaka H, Hoshikawa Y, Oh-hara T, et al. PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation[J]. Mol Cancer Res, 2009, 7(4):557-569.

[21] Hsu JM, Chen CT, Chou CK, et al. Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation[J]. Nat Cell Biol, 2011, 13(2):174-181.

[22] Wei TY, Juan CC, Hisa JY, et al. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade[J]. Cancer Sci, 2012,103(9): 1640-1650.

[23] Lim JH, Choi YJ, Cho CH, et al. Protein arginine methyltransferase 5 is an essential component of the hypoxia-inducible factor 1 signaling pathway[J]. Biochem Biophys Res Commun, 2012, 418 (2): 254-259.

[24] Hou Z, Peng H, Ayyanathan K,et al. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression[J]. Mol Cell Biol, 2008, 28(10):3198-3207.

[25] 包香香. PRMT5对上皮性卵巢癌生物学行为影响的实验研究[D]. 济南:山东大学,2013.